Letter

Nature 440, 352-357 (16 March 2006) | doi:10.1038/nature04533; Received 23 November 2005; ; Accepted 13 December 2005

A specific amyloid-bold beta protein assembly in the brain impairs memory

Sylvain Lesné1, Ming Teng Koh4, Linda Kotilinek1, Rakez Kayed6, Charles G. Glabe6, Austin Yang7, Michela Gallagher4 and Karen H. Ashe1,2,3,5

Memory function often declines with age1, and is believed to deteriorate initially because of changes in synaptic function rather than loss of neurons2. Some individuals then go on to develop Alzheimer's disease with neurodegeneration. Here we use Tg2576 mice, which express a human amyloid-beta precursor protein (APP) variant linked to Alzheimer's disease, to investigate the cause of memory decline in the absence of neurodegeneration or amyloid-beta protein amyloidosis. Young Tg2576 mice (< 6 months old) have normal memory and lack neuropathology, middle-aged mice (6–14 months old) develop memory deficits without neuronal loss, and old mice (> 14 months old) form abundant neuritic plaques containing amyloid-beta (refs 3–6). We found that memory deficits in middle-aged Tg2576 mice are caused by the extracellular accumulation of a 56-kDa soluble amyloid-beta assembly, which we term Abeta*56 (Abeta star 56). Abeta*56 purified from the brains of impaired Tg2576 mice disrupts memory when administered to young rats. We propose that Abeta*56 impairs memory independently of plaques or neuronal loss, and may contribute to cognitive deficits associated with Alzheimer's disease.

  1. Departments of Neurology and
  2. Neuroscience, and
  3. Graduate Program in Neuroscience, University of Minnesota Medical School, Minneapolis, Minnesota 55455, USA
  4. Department of Psychological and Brain Sciences, Johns Hopkins University, Baltimore, Maryland 21218, USA
  5. Geriatric Research Education Clinical Center, Minneapolis VA Medical Center, Minneapolis, Minnesota 55417, USA
  6. Department of Molecular Biology and Biochemistry, University of California, Irvine, California 92697, USA
  7. Department of Pharmaceutical Sciences, University of Southern California, Los Angeles, California 90089, USA

Correspondence to: Karen H. Ashe1,2,3,5 Correspondence and requests for materials should be addressed to K.H.A. (Email: hsiao005@umn.edu).

Received 23 November 2005 | Accepted 13 December 2005

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Alzheimer's disease A needle from the haystack

Nature News and Views (16 Mar 2006)

A welcoming environment for amyloid plaques

Nature Neuroscience News and Views (01 Apr 2003)

See all 3 matches for News And Views

Extra navigation

.

naturejobs

ADVERTISEMENT